Chari, D. M. Remyelination in Multiple Sclerosis. Int. Rev. Neurobiol. 79, 589-620 (2007).
Keegan, B. M. & Noseworthy, J. H. Multiple Sclerosis. Annu. Rev. Med. 53, 285-302 (2002).
Waxman, S. G. Demyelination in spinal cord injury and multiple sclerosis: what can we do to enhance functional recovery? J. Neurotrauma 9 Suppl 1, S105-S117 (1992).
Zhang, H., Jarjour, A. A., Boyd, A. & Williams, A. Central nervous system remyelination in culture - A tool for multiple sclerosis research. Exp. Neurol. 230, 138-148 (2011).
Kim, B. G., Hwang, D. H., Lee, S. I., Kim, E. J. & Kim, S. U. Stem cell-based cell therapy for spinal cord injury. Cell Transplant. 16, 355-364 (2007).
Rev. Neurosci. 9, 839-855 (2008).
Bradl, M. & Lassmann, H. Oligodendrocytes: biology and pathology. Acta Neuropath. 119, 37-53 (2010).
Hartline, D. K. What is myelin? Neuron Glia Biol. 4, 153-163 (2008).
Baumann, N. & Pham-Dinh, D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol. Rev. 81, 871-927 (2001).
Potter, G. B., Rowitch, D. H. & Petryniak, M. A. Myelin restoration: progress and prospects for human cell replacement therapies. Arch. Immunol. Ther. Exp. (Warsz) 59, 179-193 (2011).
The information is available from the following content providers: